HomeHealth and lifestyleWhat is R21 Oxford University malaria vaccine suggested by WHO; Read details...

What is R21 Oxford University malaria vaccine suggested by WHO; Read details HERE

The special thing is that the R21/Matrix-M vaccine is manufactured by the Serum Institute of India and it was already approved for use in Burkina Faso, Ghana, and Nigeria.

There has been a rapid increase in malaria cases not only in India but across the world. In such a situation, this news from the World Health Organization (WHO) is very relieving. In fact, the World Health Organization has approved a new malaria vaccine to prevent malaria in children. The name of this vaccine is R21/Matrix-M. Earlier in the year 2021, RTS, S/AS01 was released. This vaccine has been developed by Britain’s Oxford University. The special thing is that the R21/Matrix-M vaccine is manufactured by the Serum Institute of India and it was already approved for use in Burkina Faso, Ghana, and Nigeria.

Did WHO gives green signal

It was only after the Strategic Advisory Group of Experts on Immunization (SAGE) the Malaria Policy Advisory Group (MPAG) and the regular biennial meeting held on 25-29 September that the WHO Director-General gave the green signal. Showed it. Meanwhile, the World Health Organization (WHO), while recommending this vaccine for the prevention of malaria in children, also shared a lot of information with the people.

At the same time, the World Health Organization (WHO), recommending this vaccine to prevent malaria in children, also shared a lot of information with people.

Meanwhile, WHO chief Tedros Adhanom Ghebreyesus said, “As a malaria researcher, I dreamed of the day when we would have a safe and effective vaccine against malaria. Now we have two.”

Not only this, the WHO Chief also said that the demand for the first RTS, S vaccine far exceeds the supply, so this second vaccine is a must-have to save more children faster and bring us closer to our vision of a malaria-free future. Will serve as additional equipment.

Key features of R21 malaria vaccine

-The R21 vaccine can be helpful in reducing the transmission of malaria by 75%.

-The vaccine showed 66% effectiveness during 12 months after the first 3 doses.
-The fourth dose after one year also showed effectiveness in preventing malaria.

Let us tell you that on the advice of SAGE, WHO has also issued recommendations for new vaccines for dengue and meningitis. WHO has also issued several recommendations related to the polio vaccination program.

तमाम खबरों के लिए हमें Facebook पर लाइक करें Twitter , Kooapp और YouTube  पर फॉलो करें। Vidhan News पर विस्तार से पढ़ें ताजा-तरीन खबरें